PPT Sues Biden Administration Over Menthol Cigarette Ban

Regulations by 2FIRSTS.ai
Apr.19.2024
PPT Sues Biden Administration Over Menthol Cigarette Ban
Public Trust Protection Organization (PPT) sues Biden administration over menthol cigarette ban, alleging violation of FOIA regulations.

According to a report by Fox News on April 17, the American watchdog group "Public Trust Protection Organization" (PPT) has filed a lawsuit against the Biden administration over the ban on menthol cigarettes.

 

The organization has filed a federal lawsuit against the Department of Health and Human Services (HHS), alleging violations of the Freedom of Information Act (FOIA). Last year, the organization submitted four FOIA requests to the department and its subsidiary agency, the Food and Drug Administration (FDA), regarding the ban on menthol cigarettes, but received no response to those requests.

 

The organization's chairman, Michael Chamberlain, was formerly a communications official at the Department of Education during the Trump administration. He stated in a press release:

 

The Biden administration and the FDA may have thought that they would be seen as conquering heroes when they announced the ban on menthol cigarettes. However, they quickly discovered that politics seemed much more complicated than that. This regulation is highly controversial, and it is important for the American public to understand the factors driving government action. Mr. Biden claims to be leading the most transparent government in history, but these agencies are not providing records. This seems to suggest that they do not want the public to know certain things.

 

According to the PowerPoint presentation, in the more than 90 days since the four requests were made, HHS has not provided any response. Therefore, the organization believes that HHS has not fulfilled its legal obligation to provide the required records for Freedom of Information Act requests.

 

Currently, the PPT has sought judicial review.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT Questions South Africa’s New Bill: Lack of Distinction Between Cigarettes and E-Cigarettes, Excessive Powers Pose Governance Risks
BAT Questions South Africa’s New Bill: Lack of Distinction Between Cigarettes and E-Cigarettes, Excessive Powers Pose Governance Risks
The South African Parliament is currently reviewing the Tobacco Products and Electronic Delivery Systems Control Bill, which proposes stricter regulation of cigarettes and e-cigarettes. A corporate and regulatory head from British American Tobacco South Africa (BATSA) pointed out that the bill lacks regulatory differentiation, ignores harm-reduction potential, and may weaken the legal market while fueling illicit trade. The company has called on the government to re-evaluate the draft’s content
Aug.18 by 2FIRSTS.ai
Although not yet approved by the FDA, Altria still plans to launch its new nicotine pouch product, on! PLUS™, in the U.S
Although not yet approved by the FDA, Altria still plans to launch its new nicotine pouch product, on! PLUS™, in the U.S
Altria announced that its subsidiary, Helix, will launch a new nicotine pouch product, on! PLUS™, in the U.S. this fall, with the initial markets covering North Carolina, Texas, and Florida. The product has not yet been approved by the FDA. It is noteworthy that the launch time and regions for on! PLUS™ are highly similar to those of BAT's planned disposable e-cigarette, Vuse One.
Aug.25
BAT Japan to Launch Limited Edition glo HYPER pro HANABI EDITION
BAT Japan to Launch Limited Edition glo HYPER pro HANABI EDITION
BAT Japan to launch limited edition glo HYPER pro HANABI EDITION on July 25, celebrating "Live Life in Color" event.
Jul.23 by 2FIRSTS.ai
2Firsts Insights | Imperial Brands’ blu Teases “Summer Bundle” Featuring BLU BOX KIT and New blu 2.0
2Firsts Insights | Imperial Brands’ blu Teases “Summer Bundle” Featuring BLU BOX KIT and New blu 2.0
Imperial Brands’ e-cigarette brand blu has announced an upcoming “Summer Bundle” on its official website, highlighting cool-flavored products. Earlier this year, blu launched two pod-based devices—the BLU BOX KIT, which focuses on compatibility and safety, and blu 2.0, featuring adjustable flavor intensity and a power-saving mode.
Jul.22 by 2FIRSTS.ai
2Firsts Exclusive with ARAC: What Juul’s FDA Approval Reveals About U.S. Tobacco Regulation
2Firsts Exclusive with ARAC: What Juul’s FDA Approval Reveals About U.S. Tobacco Regulation
2Firsts spoke with the leadership team at ARAC to analyze the regulatory context and industry implications of the FDA’s approval of five Juul products. ARAC noted that the decision highlights FDA’s increasing emphasis on real-world switching behavior as a key criterion for authorization. While more MGOs may follow, companies must meet rigorous standards in toxicology, manufacturing, and population-level risk assessments.
Jul.21
2Firsts Interviews ASDF on Malaysia’s Vape Ad Ban, Total Prohibition Plans, and What’s Next
2Firsts Interviews ASDF on Malaysia’s Vape Ad Ban, Total Prohibition Plans, and What’s Next
Malaysia’s Vape Market in Turmoil.Since the implementation of Act 852, Malaysia’s e-cigarette sector has been undergoing intense upheaval. From stricter compliance inspections and a full advertising ban to a proposal for a complete sales prohibition, a regulatory storm is reshaping the industry landscape.2Firsts talks with leading local brand ASDF to learn how it is responding to challenges and laying out a compliance roadmap in the current policy environment.
Aug.14